GHRS Competitors & Alternatives
Compare GH Research PLC with similar stocks in the same industry
Biotechnology
GHRS
Main Stock$19.28
Tradestie Score
59
Market Cap
$841.74M
Analyst Upside
+103.6%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARDX
Ardelyx, Inc.
|
$6.03
|
$1.29B | - | 55 | Compare |
|
ZYME
Zymeworks Inc.
|
$27.38
|
$1.28B | - | 64 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.31
|
$1.27B | - | 48 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$37.35
|
$1.26B | - | 51 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$4.11
|
$1.22B | - | 59 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$4.07
|
$1.18B | - | 55 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$42.14
|
$1.17B | - | 58 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$23.09
|
$1.15B | 7.1 | 59 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$13.90
|
$1.14B | - | 55 | Compare |
More GHRS Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry